To prevent the "scheduling" of purported "psychedelic compounds" under the Comprehensive Drug Abuse Prevention and Control Act of 1970, 21 U.S.C. Sections 801, Et. Seq (1970) (Controlled Substance Act or act), biotechnology company Panaea Plant Sciences (PPS) sued the Drug Enforcement Administration (DEA) on April 10.